Echinocandins: The newest class of antifungals

Cited by (214)

Items 101–200 of 214

1. Synthesis and evaluation of novel macrocyclic antifungal peptides
   Monique P. C. Mulder, John A. W. Kruijtzer, Eefjan J. Breukink, Johan Kemmink, Roland J. Pieters, Rob M. J. Liskamp · 2011 · Bioorganic & Medicinal Chemistry
2. A case of Candida glabrata severe urinary sepsis successfully treated with micafungin
   Filippo Pieralli, Cristina Bazzini, Vieri Vannucchi, Antonio Mancini, Carlo Nozzoli · 2014 · Medical Mycology Case Reports
3. Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase
   Nimer Mehyar, Abdullah Mashhour, Imadul Islam, Sheraz Gul, Adeyemi O. Adedeji, Ahmed S. Al Askar, Mohamed Boudjelal · 2021 · SAR and QSAR in environmental research
4. Current Challenges and Updates on the Therapy of Fungal Infections
   Laura Nunes Silva, Thaís Pereira de Mello, Lívia S. Ramos, Marta H. Branquinha, André Luis Souza dos Santos · 2019 · Current Topics in Medicinal Chemistry
5. Fungistatic Action of N-Acetylcysteine on Candida albicans Biofilms and Its Interaction with Antifungal Agents
   Thaís Soares Bezerra Santos Nunes, Leticia Matheus Rosa, Yuliana Vega-Chacón, Ewerton Garcia de Oliveira Mima · 2020 · Microorganisms
6. Healthcare-associated fungal infections and emerging pathogens during the COVID-19 pandemic
   Krish Shah, Mukund Deshpande, P. Shah · 2024 · Frontiers in Fungal Biology
7. First electrochemical study of a potent antifungal drug caspofungin: Application to its enhanced voltammetric sensing based on the performance of boron-doped diamond electrode in CTAB-mediated measurements
   Hoshyar Saadi Ali, Hemn A.H. Barzani, Yavuz Yardım, Zühre Şentürk · 2022 · Diamond and Related Materials
8. Small molecule based anti-virulence approaches against Candida albicans infections
   Shanthini Kalimuthu, Om Alkhir Alshanta, Akshaya Lakshmi Krishnamoorthy, Akhila Pudipeddi, Adline Princy Solomon, William McLean, Yiu Yan Leung, Gordon Ramage, Prasanna Neelakantan · 2022 · Critical Reviews in Microbiology
9. Total synthesis and structure–activity relationships of caspofungin-like macrocyclic antifungal lipopeptides
   Jianzhong Yao, Hongming Liu, Ting Zhou, Hai Chen, Zhenyuan Miao, Guoqiang Dong, Shengzheng Wang, Chunquan Sheng, Wannian Zhang · 2012 · Tetrahedron
10. Ketoconazole induces reversible antifungal drug tolerance mediated by trisomy of chromosome R in Candida albicans
    Lijun Zheng, Yi Xu, Chen Wang, Liangsheng Guo · 2024 · Frontiers in Microbiology
11. Mutual influence of backbone proline substitution and lipophilic tail character on the biological activity of simplified analogues of caspofungin
    Monique P. C. Mulder, Peter Fodran, Johan Kemmink, Eefjan J. Breukink, John A. W. Kruijtzer, Adriaan J. Minnaard, Rob M. J. Liskamp · 2012 · Organic & Biomolecular Chemistry
12. Lipopeptides: Status and Strategies to Control Fungal Infection
    Piyush Baindara, Suresh Korpole · 2016 · Springer eBooks
13. Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
    Dylan J. Stolz, Ethan M. Sands, Nansalmaa Amarsaikhan, Angar Tsoggerel, Steven P. Templeton · 2018 · Journal of Visualized Experiments
14. The biosynthetic logic and enzymatic machinery of approved fungi-derived pharmaceuticals and agricultural biopesticides
    Moli Sang, Peiyuan Feng, Lu‐Ping Chi, Wei Zhang · 2023 · Natural Product Reports
15. Concomitant drugs with low risks of drug–drug interactions for use in oncology clinical trials
    Florence Ranchon, Thierry Vial, Catherine Rioufol, Émilie Hénin, Claire Falandry, Gilles Freyer, Veronique N. Trillet-Lenoir, Christophe Le Tourneau, Benoît You · 2015 · Critical Reviews in Oncology/Hematology
16. The synthesis and activity evaluation of N‐acylated analogs of echinocandin B with improved solubility and lower toxicity
    Bing dong Zhu, Yuanzhen Dong, Jie Ma, Min‐Wei Chen, Sida Ruan, Wenjie Zhao, Jun Feng · 2020 · Journal of Peptide Science
17. Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?
    Johannes Boyer, Martin Hoenigl, Lisa Kriegl · 2024 · Expert Review of Clinical Pharmacology
18. Assessing the Bioactive Profile of Antifungal-Loaded Calcium Sulfate against Fungal Biofilms
    Mark C. Butcher, Jason L. Brown, Donald Hansom, Rebecca Wilson-van Os, Craig P. Delury, Phillip A. Laycock, Gordon Ramage · 2021 · Antimicrobial Agents and Chemotherapy
19. Inhibitory mechanism of an antifungal drug, caspofungin against amyloid β peptide aggregation: Repurposing via neuroinformatics and an experimental approach
    Anchala Kumari, Nidhi Shrivastava, Mohit Mishra, Pallavi Somvanshi, Abhinav Grover · 2021 · Molecular and Cellular Neuroscience
20. First Report for the Electrooxidation of Antifungal Anidulafungin: Application to its Voltammetric Determination in Parenteral Lyophilized Formulation Using a Boron‐doped Diamond Electrode in the Presence of Anionic Surfactant
    Hande İzem Özok, Shabnam Allahverdiyeva, Yavuz Yardım, Zühre Şentürk · 2022 · Electroanalysis
21. Known Antimicrobials Versus Nortriptyline in Candida albicans: Repositioning an Old Drug for New Targets
    Caldara, Marina, Marmiroli, Nelson · 2020 · Microorganisms
22. A Review on production of echinocandins by Aspergillus sp
    Saswata Goswami, Anju Rani, Rashmi Priyadarshini, Biswanath Bhunia, Tamal Mandal · 2013 · Journal Of Biochemical Technology
23. A comparative study of in-vitro and in-silico anti-candidal activity and GC–MS profiles of snow mountain garlic vs. normal garlic
    Bhupinder Kaur, Nitish Kumar, Sonam Chawla, Deepika Sharma, Suresh Korpole, Rajni Sharma, Manoj Kumar Patel, Kanwaljit Chopra, O. P. Chaurasia, Shweta Saxena · 2022 · Journal of Applied Microbiology
24. Cdc14 phosphatase contributes to cell wall integrity and pathogenesis in Candida albicans
    Kedric L. Milholland, Ahmed AbdelKhalek, Kortany Maree Baker, Smriti Hoda, Andrew G. DeMarco, Noelle H. Naughton, Angela N Koeberlein, Gabrielle R. Lorenz, Kartikan Anandasothy, Antonio Esperilla-Muñoz et al. · 2023 · Frontiers in Microbiology
25. 1,3-Thiazine, 1,2,3,4-Dithiadiazole, and Thiohydrazide Derivatives Affect Lipid Bilayer Properties and Ion-Permeable Pores Induced by Antifungals
    Anastasiia A. Zakharova, Svetlana S. Efimova, V. N. Yuskovets, I. P. Yakovlev, Zara M. Sarkisyan, Olga S. Ostroumova · 2020 · Frontiers in Cell and Developmental Biology
26. Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies
    Francesco Giuseppe De Rosa, Alessandro Busca, Maria Rita Capparella, Jean Li Yan, Jalal A. Aram · 2021 · Clinical Drug Investigation
27. Sequential Induction of Drug Resistance and Characterization of an Initial Candida albicans Drug-Sensitive Isolate
    Setrida El Hachem, Nour Fattouh, Christy Chedraoui, Marc Finianos, Ibrahim Bitar, Roy A. Khalaf · 2024 · Journal of Fungi
28. Antifungal therapy in children: an update
    Valerio Cecinati, Chiara Guastadisegni, Fabio Giovanni Russo, Letizia Pomponia Brescia · 2012 · European Journal of Pediatrics
29. Drug Interactions Involving Antifungal Drugs: Time Course and Clinical Significance
    Ashley M. Bartell, Arti Phatak, Kirsten Horn, Michael J. Postelnick · 2010 · Current Fungal Infection Reports
30. Chromatographic Methods for Echinocandin Antifungal Drugs Determination in Bioanalysis
    Beatriz Uribe, Oskar González, Boubakar B Ba, Karen Gaudin, Rosa M. Alonso · 2019 · Bioanalysis
31. Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for invasive candidiasis in China
    Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu · 2018 · Journal of Medical Economics
32. Equinocandinas: aspectos aplicados de la farmacología
    José Ramón Azanza Perea · 2016 · Revista Iberoamericana de Micología
33. Urinary Tract Infection in HIV/AIDS Patients
    Gerardo Amaya‐Tapia, Gabriela Ibarra‐Nieto, Octavio Campollo, José Luis González Sánchez · 2023 · IntechOpen eBooks
34. Successful Rapid Desensitization to Micafungin in a Pediatric Patient
    Stephanie L. Ward, Michelle C. Maciag, Sarah M. Jones, Joyce Lee, John Lee, Ana Dioun Broyles · 2020 · Pediatric Allergy Immunology and Pulmonology
35. Current and emerging therapies for fungal biofilms and systemic infections
    Yehia Elgammal, Rafael I. Garcia Martinez, Adrian Requejo, Luis R. Martinez · 2025 · Critical Reviews in Microbiology
36. Re‐Engineering Fungal Nonribosomal Peptide Synthetases by Module Dissection and Duplicated Thiolation Domains
    Miaomiao Yin, Linan Xie, Kang Chen, Liwen Zhang, Qun Yue, Chen Wang, Juntian Zeng, Xiaoyang Hao, Xiaofeng Gu, István Molnár et al. · 2024 · Angewandte Chemie International Edition
37. Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis
    Jyoti Sankar Prusty, Awanish Kumar, Awanish Kumar · 2024 · Critical Reviews in Microbiology
38. Deacylation of Echinocandin B by Streptomyces species: a novel method for the production of Echinocandin B nucleus
    Maya Shivakumar, Shiragambi Hanumantagouda Manohar, Bhat K. Ishwar, P. Raghu, J. Savitha · 2019 · 3 Biotech
39. Opportunistic Mycoses
    Jennifer Horan Saullo, Barbara Dudley Alexander · 2015 · Elsevier eBooks
40. The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections
    Alexander V. Veselov · 2020 · Clinical Microbiology and Antimicrobial Chemotherapy
41. Experimental efficacy of anidulafungin againstAspergillus terreusspecies complex
    Marta Sanchis, Javier Capilla, Emilio Mayayo, Francisco Javier Pastor, Josep Guarro · 2015 · Medical Mycology
42. Brazilian guidelines for the management of candidiasis: a joint meeting report of three medical societies – Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia, Sociedade Brasileira de Medicina Tropical
    Arnaldo Lopes Colombo, Thaís Guimarães, Luís Fernando Aranha Camargo, Rosana Richtmann, Flávio Queiroz‐Telles, Mauro José Costa Salles, Clóvis Arns da Cunha, Maria Aparecida Shikanai‐Yasuda, Maria Luíza Moretti, Márcio Nucci · 2012 · The Brazilian Journal of Infectious Diseases
43. Design, synthesis and biological evaluation of natural product echinocandin derivatives
    Shaojie Chu, Yan Zheng, Guoping Wang, Shuangshuang Su, Hongbo Wang, Shaoxin Chen, Xuesong Wu · 2025 · European Journal of Medicinal Chemistry
44. Antifungal Drug Resistance
    Johanna L. Rhodes · 2025 · Current topics in microbiology and immunology
45. Inter-laboratory variability of caspofungin MICs for Nakaseomyces glabrata isolates – an Irish tertiary hospital experience
    Saied Ali, Meadhbh Collison, Sinéad McNicholas, Sinead McDermott · 2023 · Access Microbiology
46. Experiencia de micafungina en pacientes con técnicas de depuración extrarrenal
    F. Álvarez Lerma, Santiago Grau, Yurena Caballero Díaz, Juan Ángel Fernández · 2010 · Revista española de quimioterapia. Suplemento
47. High Performance Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Quantification of Caspofungin, Anidulafungin and Micafungin in Human Plasma for Feasible Applications in Pediatric Haematology/Oncology
    Marianna Ventura, Roberta Michelini, Nunzia Decembrino, Mariadelfina Molinaro, Marco Zecca, Simona De Gregori · 2017 · Chromatographia
48. Opciones terapéuticas frente a especies de Candida resistentes a las equinocandinas
    Andrea Patricia Cortés Hidalgo, Oscar Hernando Roa Dueñas, Yardany Rafael Méndez Fandiño, C. Á. Moreno · 2018 · Universitas Médica
49. Urinary Tract Infections - New Insights
    Wael A. H. Hegazy · 2023 · IntechOpen eBooks
50. ComparativeIn VitroSusceptibility of Clinical Isolates ofCandida parapsilosisComplex and OtherCandidaSpecies to Caspofungin and Anidulafungin by Etest
    Ziauddin Khan, Suhail Ahmad, Leena Joseph, Rachel George Chandy, A. Theyyathel · 2011 · Journal of Chemotherapy
51. Antifungal Dosing in Dialysis and Continuous Renal Replacement Therapy
    Douglas N. Fish · 2011 · Current Fungal Infection Reports
52. The cell wall protein Rhd3/Pga29 is over-expressed inCandida albicansupon micafungin treatment
    Elisabetta Vavala, Giuseppina Mignogna, Furio Spano, Annarita Stringaro, Marisa Colone, Maurizio Sanguinetti, Bruno Maras, Letizia Angiolella · 2013 · Journal of Chemotherapy
53. Interacciones farmacológicas en el paciente crítico. ¿Un factor relevante para usar micafungina?
    José Garnacho‐Montero, Francisco Jiménez Parrilla · 2011 · Enfermedades Infecciosas y Microbiología Clínica
54. Frontier in Antifungal Treatments Against Major Human Fungal Opportunistic Pathogen Candida Species and Medically Important Fungi
    Nitnipa Soontorngun, Pichayada Somboon, Kwanruthai Watchaputi · 2019 · Springer eBooks
55. Determination of antifungal caspofungin in RPMI-1640 cell culture medium by column-switching HPLC-FLD
    Beatriz Uribe, Oskar González, Isabelle Ourliac‐Garnier, Patrice Le Pape, Boubakar B Ba, Rosa M. Alonso, Karen Gaudin · 2020 · Journal of Pharmaceutical and Biomedical Analysis
56. Formulary Drug Review: Rezafungin
    Brittney Kessel, Danial E. Baker · 2023 · Hospital Pharmacy
57. How can we optimize antifungal use and stewardship in the treatment of acute leukemia?
    Thomas Taynton, David John Allsup, Gavin D Barlow · 2024 · Expert Review of Hematology
58. Natural products as alternative therapies for eye disorders: from traditional use to modern formulations
    Abdullah M. M. Elbadry, Shaza H. Aly, Nada A. Abdelrazek, Riham A. El‐Shiekh, Aya Salman, Ahmed Nabil, Ahmed Reda, Omneya Eid, Eman G. Manaa, Sherif R. Abdel-All et al. · 2026 · Beni-Suef University Journal of Basic and Applied Sciences
59. Antifungal PK/PD in the Critically Ill
    Roger J. M. Brüggemann, Dylan W. de Lange, Jan‐Willem C. Alffenaar · 2017 · Springer eBooks
60. Pharmacological importance of novel spiro derivatives against human pathogenic fungi
    G. Sharma, Richa Sharma, Richa Saxena, Ekadashi Rajni, Ved Prakash Mamoria · 2023 · Biomeditsinskaya Khimiya
61. Candida Glabrata Pneumonia in Post COVID-19 Patient: A Rare Case Report
    Jahja Teguh Widjaja, Evelyn Nathania · 2023 · Jurnal Respirologi Indonesia
62. Abnormal sterol-induced cell wall glucan deficiency in yeast is due to impaired glucan synthase transport to the plasma membrane
    Leydi Roxana Gutiérrez Armijos, Rodrigo A. C. Sussmann, Ariel Mariano Silber, Mauro Cortéz, Agustín Hernández · 2020 · Biochemical Journal
63. Antifungal Agents in Current Pediatric Practice
    Valerio Cecinati, Teresa Perillo, Letizia Pomponia Brescia, Fabio Giovanni Russo · 2013 · Current Infectious Disease Reports
64. [Experience of micafungin in patients requiring extrarenal depuration].
    Francisco Álvarez-Lerma, Santiago Grau, Yurena Caballero Díaz, J Fernández · 2010 · PubMed
65. Echinocandins
    Malini Rajinder Capoor, Abhijit M. Bal · 2022 · Elsevier eBooks
66. Antifungal Drugs
    Beatriz Bustamante, José Antonio Maradona Hidalgo, Pablo Eduardo Campos · 2017 · Springer eBooks
67. Emergence of Multidrug Resistance Microbes: Bacteria, Fungi, and Viruses
    Neha Malhotra, Pramod Kumar, Sethu Ramakrishnan, Sanjay Kumar Rohaun · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
68. Reduced Cdc14 phosphatase activity impairs septation, hyphal differentiation and pathogenesis and causes echinocandin hypersensitivity in Candida albicans
    Kedric L. Milholland, Ahmed AbdelKhalek, Kortany Maree Baker, Smriti Hoda, Andrew G. DeMarco, Noelle H. Naughton, Angela N Koeberlein, Gabrielle R. Lorenz, Kartikan Anandasothy, Antonio Esperilla-Muñoz et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
69. Successful Treatment of Azole-Resistant Candida Esophagitis in an Immunocompromised Pregnant Woman Using Anidulafungin
    Conner O. Blackwell, Anandi N. Sheth, Minh Ly Nguyen, Martina L. Badell · 2017 · Annals of Pharmacotherapy
70. Rezafungin vs caspofungin for the treatment of invasive candidiasis: A systematic review and meta-analysis
    Mohammad Al Diab Al Azzawi, Wejdan Abdat, Arina Alhamed, Amjad Salman A Alhothali, Razan Alsheikh, Hind Mohammed Almajed, Sultan Ibrahim S Alhamdi, Norah Nasser A Alshahrani, Abdalla Osman Eltayeb · 2025 · Diagnostic Microbiology and Infectious Disease
71. Novel Targets and Nanotechnology Approaches in Treating Vulvovaginal Candidiasis: Insights into Host-Microbe Interactions and Immunotherapy
    Astha Lalwani, S.D. Singh, Suparna Parua, Deepika Ahuja, Krishnendu Adhikary, Rajkumar Maiti, Koushik Bhattacharya, Sourajit Kumar Banerjee, Alak Kumar Syamal · 2025 · Current Pharmaceutical Design
72. The activity of micafungin against clinical isolates of non-albicans Candida spp.
    Anna Biernasiuk, Ewelina Dobiecka, Grazyna Zdzienicka, Anna Malm · 2015 · Current Issues in Pharmacy and Medical Sciences
73. Early Recognition of Invasive Candidiasis in the ICU
    Pierre‐Emmanuel Charles, Rémi Bruyère, Frédéric Dalle · 2012 · Springer eBooks
74. Clinical Relevance of In Vitro Resistance of Echinocandins: a Focus on Candida parapsilosis
    Pramodini B. Kale-Pradhan, Sheila M. Wilhelm, Leonard B. Johnson · 2012 · Current Fungal Infection Reports
75. Candidiasis and the impact of flow cytometry on antifungal drug discovery
    Tsun Sheng N. Ku, Stella M. Bernardo, Carla J. Walraven, Samuel A. Lee · 2017 · Expert Opinion on Drug Discovery
76. Re‐Engineering Fungal Nonribosomal Peptide Synthetases by Module Dissection and Duplicated Thiolation Domains
    Miaomiao Yin, Linan Xie, Kang Chen, Liwen Zhang, Qun Yue, Chen Wang, Juntian Zeng, Xiaoyang Hao, Xiaofeng Gu, István Molnár et al. · 2024 · Angewandte Chemie
77. Updating information of mycoses and antifungal medicines to find effective platforms for the production of new thiazole compounds
    Татьяна Федоровна Черных, O. Yu. Bogdanova, Елена Владимировна Флисюк, Yu. M. Kotsur, K. O. Sidorov, И. А. Наркевич · 2024 · Drug development & registration
78. Management of Invasive Candidiasis in the Critically Ill
    José Garnacho‐Montero, Ana Díaz‐Martín, Juan Antonio Márquez-Vácaro · 2012 · Springer eBooks
79. Pharmacologie des antifongiques systémiques
    Émilie Penet, Laetitia Bonneau, Anne-Sophie Parinaud, Sophie Gonnin, Marie-Agnès Gaillard, Madeleine Javerliat · 2011 · Actualités Pharmaceutiques Hospitalières
80. Antifungal Agents
    Gerri S. Hall, Jennifer Sekeres, Elizabeth A. Neuner, James O. Hall · 2011 · Humana Press eBooks
81. The Development of Photo-activated Antimicrobial Dyes Against Opportunistic Infections
    Murhaf Jalab · 2020 · CLOK (University of Central Lancashire)
82. The pharmaceutical industry and development of antimicrobials
    Eleanor Woodford Guegan · 2010 · Journal of Infection Prevention
83. Suivi thérapeutique pharmacologique des antifongiques : utile ?
    Christophe Padoin · 2016 · Journal des Anti-infectieux
84. Probing the interaction between daptomycin and model membranes
    Jin Zhang · 2016 · cIRcle (University of British Columbia)
85. Monitoring and use of antimycotic (micafungin) for systemic use provided by the pharmacy of Marsala Hospital, Italy
    Fabio Venturella, Maria Cristina Tumbarello, Laura Navarra, Simona Martorana · 2016 · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
86. Mechanisms of Action of Antifungal Agents
    Stephanie A. Flowers, P Rogers · 2015 · CRC Press eBooks
87. Rapid Antifungal Susceptibility Testing by Matrix-Assisted Laser Desorption Ionization Time-of- 1
    Antonietta Vella, Elena De Carolis, David S. Perlin, Brunella Posteraro, Maurizio Sanguinetti, Daltonik Bruker · 2013
88. Influência de TLR3 em modelo de Paracoccidioidomicose experimental
    Grasielle Pereira Jannuzzi · 2018
89. Candida species variability as seen through clinical covariates and drug susceptibility testing
    Jesse Lee Hollanbaugh · 2010
90. Candida albicans adaption to host microenvironments drives immune evasion
    José Pedro Lopes · 2018 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
91. Multidrug Resistance Transcriptional Regulatory Networks in Candida
    Phillip David Rogers, Katherine S. Barker · 2014 · ASM Press eBooks
92. Anti-Infectives
    Zachariah Thomas, Dorothy McCoy · 2011 · Springer eBooks
93. Acute Multiple In-Stent Thromboses in a Patient With Clopidogrel-Fluconazole Interaction
    Antoine El Khoury, Zela Maria Butchakdjian, Elham Lagha, Peter Semaan, Maroun Soueidy · 2022 · Cureus
94. Combating human fungal infections
    Manzoor Ahmad Mir, Hafsa Qadri, Shariqa Aisha, Abdul Haseeb Shah · 2022 · Elsevier eBooks
95. Combinatorial approach to combat drug resistance in human pathogenic fungi
    Manzoor Ahmad Mir, Hafsa Qadri, Shariqa Aisha, Abdul Haseeb Shah · 2022 · Elsevier eBooks
96. Atividade sinérgica do antidepressivo sertralina associada a caspofungina contra Trichophyton rubrum e avaliação dos mecanismos de resposta adaptativa
    Carlos Henrique Lopes Rocha · 2023
97. Candidiasis
    Catherine M. Bendel, Elizabeth C. Swanson · 2024 · Elsevier eBooks
98. Caspofungin: Chemical characters, antifungal activities, and mechanism of actions
    Sura H. MOHAMED, Ali Abdul Hussein S. AL‐Janabi, Atheer Hameid Odda · 2024 · Gazzetta Medica Italiana Archivio per le Scienze Mediche
99. Oteseconazole (Vivjoa): A CYP51 Inhibitor for Treating Recurrent Vulvovaginal Candidiasis
    Jie Jack Li · 2024
100. Mucormycosis: Current Perspectives on Treatment, Diagnosis, and Advancements
     Tanya Biswas, Vikram Sharma, Ravi Kumar Mittal · 2024 · Coronaviruses